GSK Consumer Sales Remain Strong As Rx Revenue Slips
This article was originally published in The Tan Sheet
Executive Summary
Sales of GlaxoSmithKline's OTC and other consumer health care products far outpaced its prescription drugs, which brought overall sales down 3 percent in the firm's fiscal 2008 first quarter
You may also be interested in...
GSK Alli Strategy Relies Even More On Users Spreading The Word
Heading into its second year selling weight-loss drug alli over the counter, GlaxoSmithKline wants users to do the talking
GSK Alli Strategy Relies Even More On Users Spreading The Word
Heading into its second year selling weight-loss drug alli over the counter, GlaxoSmithKline wants users to do the talking
GSK Alli Strategy Relies Even More On Users Spreading The Word
Heading into its second year selling weight-loss drug alli over the counter, GlaxoSmithKline wants users to do the talking